U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07103642) titled 'EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)' on July 29.
Brief Summary: A retrospective real-world data study, assessing the relationship between the timing of Budesonide/Glycopyrrolate/Formoterol initiation following an exacerbation and the occurrence of subsequent exacerbations, severe cardiopulmonary events and other real-world outcomes in Japan
Study Start Date: Aug. 15, 2024
Study Type: OBSERVATIONAL
Condition:
Pulmonary Disease, Chronic Obstructive
Intervention:
DRUG: BGF
BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL
Recruitment Status: COMPLETED
Sponsor: AstraZeneca
D...